Aqu Alu

1.8k total citations · 2 hit papers
22 papers, 1.0k citations indexed

About

Aqu Alu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Aqu Alu has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Aqu Alu's work include SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (2 papers) and COVID-19 Clinical Research Studies (2 papers). Aqu Alu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (2 papers) and COVID-19 Clinical Research Studies (2 papers). Aqu Alu collaborates with scholars based in China, United States and Portugal. Aqu Alu's co-authors include Yuquan Wei, Xiawei Wei, Xuejiao Han, Jingwen Luo, Xuelei Ma, Yang Wang, Lei Hong, Shi H, Xiaohe Tian and Qingfang Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Molecular Cancer.

In The Last Decade

Aqu Alu

21 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intranasal COVID-19 vaccines: From bench to bed

2022 162 citations Aqu Alu, Li Chen et al. EBioMedicine profile →
Targeted therapy for head and neck cancer: signaling pathways and clinical studies

2023 135 citations Qingfang Li, Yan Tie et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Aqu Alu

Since Specialization

Citations

This map shows the geographic impact of Aqu Alu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aqu Alu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aqu Alu more than expected).

Fields of papers citing papers by Aqu Alu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aqu Alu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aqu Alu. The network helps show where Aqu Alu may publish in the future.

Co-authorship network of co-authors of Aqu Alu

This figure shows the co-authorship network connecting the top 25 collaborators of Aqu Alu. A scholar is included among the top collaborators of Aqu Alu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aqu Alu. Aqu Alu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway 2025 ·Cancer Communications ·Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei	2
2	Immunosenescence: signaling pathways, diseases and therapeutic targets 2025 ·Signal Transduction and Targeted Therapy ·(unknown), (unknown), Aqu Alu, Weiqi Hong, Lei Hong, Xuemei He, Shi H, Ping Cheng, Xiangliang Yang	9
3	Intranasal Inoculation of Cationic Crosslinked Carbon Dots‐Adjuvanted Respiratory Syncytial Virus F Subunit Vaccine Elicits Mucosal and Systemic Humoral and Cellular Immunity 2025 ·MedComm ·Lei Hong, Aqu Alu, H. J. Yang, Cai He, Jie Shi, Weiqi Hong, Dandan Peng, (unknown), (unknown), (unknown), (unknown), (unknown), Lijiao Pei, Xuemei He, Hong Yan, Guangwen Lu, Xiangrong Song, Xiawei Wei, Yuquan Wei	3
4	Ad‐E6/7‐HR vaccine improves the prophylactic and therapeutic efficacy in HPV‐associated cancers 2025 ·Clinical and Translational Medicine ·(unknown), Ke Qiu, (unknown), Maosen Xu, (unknown), Aqu Alu, (unknown), (unknown), Yu Zhang, (unknown), (unknown), Jie Shi, (unknown), Yuquan Wei, Jianjun Ren, Yu Zhao, Ping Cheng, Xiawei Wei	0
5	Honokiol Exhibits Anti-Tumor Effects in Breast Cancer by Modulating the miR-148a-5p-CYP1B1 Axis 2024 ·The American Journal of Chinese Medicine ·Xuejiao Han, Yuan Cheng, Z. X. Jiang, Aqu Alu, Xuelei Ma	3
6	A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2 2023 ·SHILAP Revista de lepidopterología ·Cai He, Aqu Alu, Lei Hong, H. J. Yang, Weiqi Hong, Xiangrong Song, Jiong Li, Li Yang, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei	11
7	Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants 2023 ·Nature Communications ·Lei Hong, Aqu Alu, H. J. Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, (unknown), Xuemei He, Li Yang, Jiang Li, Zhenling Wang, Wei Wang, Yuquan Wei, Shuaiyao Lu, Guangwen Lu, Xiangrong Song, Xiawei Wei	30
8	Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection 2023 ·Signal Transduction and Targeted Therapy ·H. J. Yang, Weiqi Hong, Lei Hong, Cai He, Wenwen Lei, Yanan Zhou, Tingmei Zhao, Aqu Alu, Xuelei Ma, (unknown), Li Yang, Zhenling Wang, Wei Wang, Guangwen Lu, Guobo Shen, Shuaiyao Lu, Guizhen Wu, Shi H, Xiawei Wei	20
9	Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses 2023 ·Genes & Diseases ·Li Chen, Wenyan Ren, Hong Lei, Jiayu Wang, Haiying Que, Dandan Wan, Aqu Alu, Dandan Peng, Minyang Fu, Weiqi Hong, (unknown), Xiangrong Song, Guangwen Lu, Xiawei Wei	1
10	Targeted therapy for head and neck cancer: signaling pathways and clinical studies breakdown → 2023 ·Signal Transduction and Targeted Therapy ·Qingfang Li, Yan Tie, Aqu Alu, Xuelei Ma, Shi H	135
11	Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants 2022 ·Signal Transduction and Targeted Therapy ·Lei Hong, Aqu Alu, H. J. Yang, Wenyan Ren, Cai He, Tianxia Lan, Xuemei He, Li Yang, Jiong Li, Zhenling Wang, Xiangrong Song, Wei Wang, Guangwen Lu, Xiawei Wei	31
12	Intranasal COVID-19 vaccines: From bench to bed breakdown → 2022 ·EBioMedicine ·Aqu Alu, Li Chen, Lei Hong, Yuquan Wei, Xiaohe Tian, Xiawei Wei	162
13	Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy 2022 ·Bioactive Materials ·Xuejiao Han, Aqu Alu, Hongmei Liu, Yi Shi, Xiawei Wei, Lulu Cai, Yuquan Wei	105
14	BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies 2022 ·Journal of Hematology & Oncology ·Aqu Alu, (unknown), Xuejiao Han, Yuquan Wei, Xiawei Wei	86
15	ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma 2022 ·Cancer Letters ·Yanlin Song, Yuan Cheng, Tianxia Lan, (unknown), Yü Liu, Zhenfei Bi, Aqu Alu, (unknown), Yuquan Wei, Xiawei Wei	5
16	The modulatory effect of high salt on immune cells and related diseases 2022 ·Cell Proliferation ·(unknown), Aqu Alu, Yuquan Wei, Xiawei Wei, Min Luo	31
17	Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19 2021 ·Molecular Biomedicine ·Yanghong Ni, Aqu Alu, Lei Hong, Yang Wang, Min Wu, Xiawei Wei	20
18	Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods 2021 ·Frontiers in Oncology ·Xuejiao Han, Jing Yang, Jingwen Luo, (unknown), Zilong Zhang, Aqu Alu, Yinan Xiao, Xuelei Ma	15
19	cGAS-STING pathway in cancer biotherapy 2020 ·Molecular Cancer ·Yang Wang, Jingwen Luo, Aqu Alu, Xuejiao Han, Yuquan Wei, Xiawei Wei	265
20	The role of lysosome in regulated necrosis 2020 ·Acta Pharmaceutica Sinica B ·Aqu Alu, Xuejiao Han, Xuelei Ma, Min Wu, Yuquan Wei, Xiawei Wei	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact